Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated to v3.4.2, replacing the previous v3.4.1.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no changes to study details or page layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a 'Show glossary' option to help users understand terms. The page now shows 'Last Update Submitted that Met QC Criteria' and a revision label 'Revision: v3.4.0', with minor wording refinements for FEAR Act data.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page's revision label updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study Locations section has been expanded to list multiple sites across the US, Canada, Europe, Australia, and Asia, giving potential participants clearer access to participating centers. This improves visibility of where the study is conducted and helps users identify nearby sites.SummaryDifference3%

- Check91 days agoChange DetectedNew text states that publications are provided voluntarily by the person entering study information and that some publications are automatically filled from PubMed. The revision version is updated to v3.3.2.SummaryDifference0.3%

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.